Title : Cabozantinib is selectively cytotoxic in acute myeloid leukemia cells with FLT3-internal tandem duplication (FLT3-ITD).

Pub. Date : 2016 Jul 1

PMID : 27060207






7 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Cabozantinib is selectively cytotoxic in acute myeloid leukemia cells with FLT3-internal tandem duplication (FLT3-ITD). cabozantinib fms related receptor tyrosine kinase 3 Homo sapiens
2 Cabozantinib is selectively cytotoxic in acute myeloid leukemia cells with FLT3-internal tandem duplication (FLT3-ITD). cabozantinib fms related receptor tyrosine kinase 3 Homo sapiens
3 We found that cabozantinib was significantly cytotoxic to MV4-11 and Molm-13 cells that harbored FLT3-ITD, resulting in IC50 values of 2.4 nM and 2.0 nM, respectively. cabozantinib fms related receptor tyrosine kinase 3 Homo sapiens
4 However, K562, OCI-AML3 and THP-1 (leukemia cell lines lacking FLT3-ITD) were resistant to cabozantinib, showing IC50 values in the micromolar range. cabozantinib fms related receptor tyrosine kinase 3 Homo sapiens
5 Cabozantinib arrested MV4-11 cell growth at the G0/G1 phase within 24 h, which was associated with decreased phosphorylation of FLT3, STAT5, AKT and ERK. cabozantinib fms related receptor tyrosine kinase 3 Homo sapiens
6 Thus, cabozantinib is selectively cytotoxic to leukemia cells with FLT3-ITD, causing cell-cycle arrest and apoptosis. cabozantinib fms related receptor tyrosine kinase 3 Homo sapiens
7 Clinical trials evaluating the efficacy of cabozantinib in acute myeloid leukemia (AML) with FLT3-ITD are warranted. cabozantinib fms related receptor tyrosine kinase 3 Homo sapiens